PyroCarbon MCP Joint May Provide Stiff Competition For Silicone Alternative
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of Ascension Orthopedics' PyroCarbon MCP (metacarpophalangeal prosthesis) total finger joint replacement would preclude the need for silicone MCP joint replacements in early-stage arthritis patients, the company claims.
You may also be interested in...
Ascension MCP Approval Should Not Include Postmarket Study Requirement
Ascension Orthopedics' ten-year follow-up data on the Ascension MCP total metacarpophalangeal finger joint replacement obviates the need for a postmarket study, according to FDA's Orthopedics and Rehabilitation Devices Advisory Panel.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”